MedPath

Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis

Active, not recruiting
Conditions
Coxarthrosis
Interventions
Device: Ostenil® Plus
Registration Number
NCT03809962
Lead Sponsor
TRB Chemedica AG
Brief Summary

PMCF study to observe the Routine application of Ostenil® Plus in the Treatment of pain and restricted mobility in degenerative and traumatic changes of the Hip Joint.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  1. Subjects ≥ 18 years of age and in good general health condition
  2. Signed informed consent
  3. Existing Ostenil® Plus recommendation for the treatment of coxarthrosis
Exclusion Criteria
  1. Known hypersensitivity to one of the OSTENIL® PLUS components
  2. Known pregnancy or lactating females
  3. Previous/concomitant participation in clinical investigation within the last 3 months prior to study inclusion
  4. Subjects not capable of contracting and of understanding the nature, risks, significance and implications of the clinical investigation and unable to form a rational intention in the light of these facts
  5. Subjects unable to understand informed consent or having a high probability of non compliance to the study procedures and / or non completion of the study according to investigator's judgement (e.g. illiteracy, insufficient knowledge of local language)

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Ostenil® PlusOstenil® Plus1-3 injections of sodium hyaluronate 2% (40 milligrams (mg) / 2,0 millilitres (ml)) in weekly interval.
Primary Outcome Measures
NameTimeMethod
Change of Subjective Symptom Evaluation (Overall Impression on a scale from 1 to 5)Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

The Change of Overall Subjective Symptom Evaluation on a scale from 1 (much improved) to 5 (much worse).

Change of Subjective Therapy Evaluation of Stiffness (HOOS Questionnaire) compared to BaselineDay 84 after last injection, Day 168 after last injection

Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Stiffness on a 5-point Likert scale

Change of Subjective Therapy Evaluation of Quality of Life (HOOS Questionnaire) compared to BaselineDay 84 after last injection, Day 168 after last injection

Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Quality of Life on a 5-point Likert scale

Change of Pain Intensity compared to Baseline (VAS-slider)Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

Evaluation of Pain Intensity by the Patient on a 10 cm VAS-slider (10 cm equals the most pain)

Change of Subjective Therapy Evaluation of Pain (HOOS Questionnaire) compared to BaselineDay 84 after last injection, Day 168 after last injection

Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Pain on a 5-point Likert scale

Change of Range of Motion compared to Baseline (Goniometer measurement)Day 7, Day 14, Day 84 after last injection, Day 168 after last injection

Assessment of the Range of internal and exernal rotation of the Hip Joint using a Goniometer.

Incidence of Treatment-Emergent Adverse EventsUp to Day 252 after the last injection
Change of Subjective Therapy Evaluation of Function in daily living (HOOS Questionnaire) compared to BaselineDay 84 after last injection, Day 168 after last injection

Hip Disability and Osteoarthritis Outcome Score (HOOS) to assess Function in daily living on a 5-point Likert scale

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (7)

Gemeinschaftspraxis für Orthopädie und Unfallchirurgie

🇩🇪

Bad Oldesloe, Schleswig-Holstein, Germany

Orthopraxis Kiel

🇩🇪

Gettorf, Schleswig-Holstein, Germany

Zentrum für Medizin des Bewegungsapparates

🇩🇪

Heide, Schleswig-Holstein, Germany

Orthopädische Praxis Rahlstedt

🇩🇪

Hamburg, Germany

Orthopädie Praxis

🇩🇪

Ramelsloh, Germany

OrthopädieZentrum Maschen

🇩🇪

Seevetal, Germany

Orthopädische Gemeinschaftspraxis Eutin

🇩🇪

Eutin, Germany

© Copyright 2025. All Rights Reserved by MedPath